Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
暂无分享，去创建一个
W. Klapper | B. Burkhardt | E. Macintyre | D. Deforce | G. Basso | J. Meijerink | N. Van Roy | P. Van Vlierberghe | B. Accordi | V. Serafin | F. Matthijssens | F. van Nieuwerburgh | J. Bourquin | T. Tousseyn | A. Uyttebroeck | P. Vandenberghe | S. Goossens | J. Roels | B. De Moerloose | T. Lammens | Y. Benoît | B. Bornhauser | Y. Tsai | J. Morscio | L. Mussolin | B. Lintermans | F. Lovisa | S. Jenni | A. Touzart | S. Peirs | R. De Smedt | Lindy Reunes | Sofie Peirs